The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Ferring Presents New Data Analyses for REBYOTA®
Infectious Disease & AMR

Ferring Presents New Data Analyses for REBYOTA®

NOV 4, 2025
Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection
Finance

Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection

NOV 3, 2025
Seres Therapeutics Receives Award of up to $3.6M from Carb-X to Develop Liquid Formulation of Ser-155
Finance

Seres Therapeutics Receives Award of up to $3.6M from Carb-X to Develop Liquid Formulation of Ser-155

OCT 31, 2025
Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis
Clinical & Manufacturing

Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis

OCT 29, 2025
Scientists develop a way to track donor bacteria after fecal microbiota transplants
Pharma & Human Health

Scientists develop a way to track donor bacteria after fecal microbiota transplants

OCT 27, 2025
Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome
Gastrointestinal

Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome

OCT 17, 2025
Phagos Raises €25m Series A
Animal Health

Phagos Raises €25m Series A

OCT 10, 2025
New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event
Gut-Brain Axis

New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event

OCT 8, 2025
EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region
Gastrointestinal

EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region

SEP 29, 2025
Multi-omic data from study of the longest-lived person ever recorded sheds light on biology of ageing
Pharma & Human Health

Multi-omic data from study of the longest-lived person ever recorded sheds light on biology of ageing

SEP 26, 2025
Study finds significant health benefits in adolescents with obesity treated with FMT
Pharma & Human Health

Study finds significant health benefits in adolescents with obesity treated with FMT

SEP 24, 2025